RxDoctor Payments Data

William Montross, DPM

Foot & Ankle Surgery · Colorado Springs, CONPI 1225018898

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (28.4%), other and royalties or licence payments — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Linvatec Corporation at 29.6% of the total. Reporting peaked in 2022 at $64,156 and has fallen 72.5% since, to $17,634 in 2025. Among foot & ankle surgery clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$237,809in general payments, 2019–2025

Across 255 payments — averaging $932.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$71K
  • Integra Lifesciences Corporation$53K
  • Orthofix Medical, Inc.$34K
  • Stryker$24K
  • Vilex LLC$21K
  • Medical Device Business Services, Inc.$19K
  • plus $16K from 17 others
$1,118in ownership & investment interests, 2019–2025

Across 1 payment — averaging $1117.81 each. An ownership or investment interest held by the physician or an immediate family member.

  • Oxford Performance Materials, Inc.$1K

What the payments were for

  • Royalty or licence$52,66722%
  • Consulting fees$67,57228%
  • Speaking & faculty fees$12,1505%
  • Travel & lodging$32,00113%
  • Food & beverage$6,0253%
  • Education$2,1881%
  • Other$65,20627%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$237,809 in reported general payments places this provider in the 95th percentile of 181 foot & ankle surgery providers in Colorado.

See all foot & ankle surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$107,364
Medicare patients
428
Services billed
1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate17$268
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$121
Methylprednisolone14$113
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$72
Tramadol Hcl12$18

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →